André Alker
Active 2007–2024
- 8
- Papers
- 542
- Citations
- 8
- h-index
- 8
- i10-index
Self-citations are included in these numbers.
Citations per year
Citations
Citation sources
Countries
This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.
Institutions
- Pfizer (United States)13.4%
- ETH Zurich13.2%
- Roche (Switzerland)12.7%
- University of Padua8.5%
- Gilead Sciences (United States)8.3%
- Age UK6.3%
- Other37.7%
Fields
- Medicine49.2%
- Chemistry24.6%
- Biochemistry, Genetics and Molecular Biology12.3%
- Computer Science5.7%
- Pharmacology, Toxicology and Pharmaceutics4.9%
- Engineering1.6%
- Other1.6%
Topics
- Chemical Synthesis and Analysis12.6%
- Synthesis and Catalytic Reactions12.1%
- Hepatitis C virus research11.1%
- HIV/AIDS drug development and treatment9.6%
- Computational Drug Discovery Methods8.1%
- Hepatitis B Virus Studies8.1%
- Other38.4%
Frequent coauthors
- Abdirisak Ahmed Isse2
- Anja Osterwald2
- Caterina Bissantz2
- Christoph Ullmer2
- Claudia Korn2
- Elisabeth A. Zirwes2
- Erick M. Carreira2
- Han Ma2
- Helmut R. Mäcke2
- Isabel Nájera2
- Jürgen Fingerle2
- Klaus Klumpp2
- Marianna Tosato2
- Mark Rogers‐Evans2
- Mark Smith2
- Matthias Nettekoven2
- Mauro Maccarrone2
- Nick Cammack2
- Nicole Inocencio2
- Sophie Le Pogam2
- Uwe Grether2
- Valerio Di Marco2
- Vincent Lévêque2
- Wen-Rong Jiang2
All papers
Loading papers…
